|
 |
| home > pmps > autumn 2003 > quality: a strategic element in the success of a company |
|
|
 PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer
|
The convention opened with a short introduction by Sergio Dompé, President of the convention organiser and the Chairman, Prof Andrea Gazzaniga, Professor of Pharmacy at the University of Milano, who warmly welcomed the upcoming lectures by key experts from across the world in pharmaceutical quality issues. Dr Henning G Kristensen, who at present serves as the Chair of the European Commission and is a member of the Steering committee for the Certificates of Suitability of Drug Substances, spoke first, on The European Pharmacopoeia and its role in the regulatory process, highlighting the difficulties found in the integration of the Pharmacopoeias in the differing European countries.
The message was that European countries need to speak a common technical language and establish an international harmonisation of subjects. Certain uniformity in the terminology related to pharmaceutical products' qualitative characteristics and in the impurities controls, both for the active pharmaceutical ingredients (API) and excipients and for the container materials, should be reached in the next few years. In the 4th Edition of European Pharmacopoeia it is stated that those standards have to be appropriate to the needs of all people engaged in quality controls laboratories and in the manufacturers of starting materials too.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
4th Annual Patient Recruitment and Retention in Clinical Trials
13-15 October 2008, Amsterdam
Patient recruitment
is now consuming thirty percent of clinical trial time - more time than any
other clinical trial activity - and almost half of all trial delays result from
patient recruitment problems.
As the
recruiting culture becomes more sophisticated and the forces affecting patient
enrollment grow more numerous and complex, pharmaceutical companies are
striving to discover new strategies to facilitate enrollment in clinical
trials.
With
increasing industry pressure to develop, test and market greater numbers of new
drugs faster, pharmaceutical companies need to perform clinical trials as
quickly as possible. Inefficient patient recruitment processes is a formidable
barrier to pharmaceutical companies' success in launching new products.
Improving the patient recruitment process is imperative to avoid wasted
investments and eliminate costly delays in bringing new drugs to market --
today and even more so in the not-so-distant future. Improved patient
recruitment presents one of the largest opportunities for pharmaceutical
companies to eliminate delays in clinical trials, thereby making it possible to
reduce time to market. With patent time limits and large overheads
meaning that any delays in the development timeline can be disastrous, a good
understanding of how to successfully recruit patients for trials is vital for
any company looking to succeed.
More info >> |
|
 |
News and Press Releases |
 |
New PFA SonicLine® ultrasonic flowmeters
Flow measurement with ultrasound fast, precise, free from contamination The new PFA SonicLine® ultrasonic flowmeters assure precise measurement and control of chemical consumption and management of chemical stocks with high reliability. SonicLine® is also ideally suited for accurate batch and dosing processes with high reproducibility.
More info >> |
|
 |
